Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Hyatt Regency Bethesda

Feb 24, 2025 7:00 AM - Feb 25, 2025 4:20 PM

One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814-5326

Advertising and Promotion Regulatory Affairs Conference

Advancing Advertising and Promotion in the Age of Innovation

Early Bird Registration Expires

DAYS

HOURS

MINUTES

SECONDS

Session 2: Insights from the FDA and Industry on Implementation – Policies and Regulations

Session Chair(s)

Twyla  Mosey, PharmD

Twyla Mosey, PharmD

Division Director

FDA, United States

Catherine  Gray, PharmD

Catherine Gray, PharmD

Director, Office of Prescription Drug Promotion, OMP, CDER

FDA, United States

This session will provide further FDA insight into policies and regulations and allow for an interactive discussion between FDA and industry on best practices and tools for implementation.

Learning Objective :
  • Interpret FDA policies and regulations to help develop compliant prescription drug advertising and promotion
  • Discuss key takeaways and learnings regarding the future of social media, the CCN Final Rule and compliance activities
  • Identify common pitfalls with prescription drug promotion and discuss tools and strategies to address them

Speaker(s)

Twyla  Mosey, PharmD

Speaker

Twyla Mosey, PharmD

FDA, United States

Division Director

Lisa  Hubbard

Speaker

Lisa Hubbard

Opus Regulatory, Inc., United States

Principal Consultant

Josephine  Secnik, MBA, MS

Speaker

Josephine Secnik, MBA, MS

Eli Lilly and Company, United States

Executive Director – Product Communications Regulatory Affairs

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.